GlassScriptPhysician profile
Robert Francis Solarczyk
NPI 1982691192
$3,600.62
in general payments reported to CMS, 2019-2025
23 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,110 · 2022: $760 · 2023: $717 · 2024: $818 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,730.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,337.07 | 2021-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $907.96 | 2021-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $242.18 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Redhill Biopharma INC. | $141.73 | 2021 | |
| Mallinckrodt Hospital Products INC. | $125.16 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $112.54 | 2021 | |
| Boston Scientific Corporation | $111.27 | 2021-2024 | |
| Valinor Pharma, LLC | $81.36 | 2023-2024 | Movantik |
| Stimwave Technologies Incorporated | $65.21 | 2021-2022 | |
| Si-Bone, INC. | $60.89 | 2024 | |
| Averitas Pharma INC. | $59.80 | 2023-2024 | Qutenza |
| Virtus Pharmaceuticals LLC | $59.48 | 2021-2022 | |
| Protega Pharmaceutials INC | $52.68 | 2024 | Roxybond |
| Amneal Pharmaceuticals LLC | $40.16 | 2022-2023 | Lyvispah |
| Radius Health, INC. | $32.84 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $29.70 | 2021 | |
| Mml US, INC. | $27.14 | 2025 | Reactiv8 |
| Convatec INC. | $26.12 | 2024 | |
| Uswm, LLC | $26.10 | 2021 | |
| Abbott Laboratories | $19.97 | 2025 | Proclaim |
| Acelrx Pharmaceuticals, INC. | $19.66 | 2022 | |
| Forte Bio-Pharma LLC | $13.38 | 2021 | |
| Metacel Pharmaceuticals LLC | $8.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Solarczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.